80 related articles for article (PubMed ID: 854865)
1. Observations on dibromodulcitol (DBD)-mitolactol-treatment.
Perényl G; Büttner K; Dénes L
Ther Hung; 1977; 25(1):16-9. PubMed ID: 854865
[No Abstract] [Full Text] [Related]
2. Preliminary experience with Mitolactol in advanced tumors of the orofacial region and the larynx.
Cichý A; Grobarcíková E; Klimo J; Jurga L; Pivonka M
Neoplasma; 1976; 23(4):427-34. PubMed ID: 1004654
[TBL] [Abstract][Full Text] [Related]
3. Results obtained with Dibromodulcitol (DBD) in the therapy of upper respiratory tract tumours.
Polyánszky T; Sellei C
Ther Hung; 1974; 22(3):112-5. PubMed ID: 4445979
[No Abstract] [Full Text] [Related]
4. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
[TBL] [Abstract][Full Text] [Related]
5. Effect of Mitolactol (Dibromodulcitol) treatment in bladder cancer.
Vecsey D
Ther Hung; 1978; 26(2):67-72. PubMed ID: 684658
[No Abstract] [Full Text] [Related]
6. Phase II study of dibromodulcitol (NSC-104800).
Andrews NC; Weiss AJ; Wilson W; Nealon T
Cancer Chemother Rep; 1974; 58(5 Pt 1):653-60. PubMed ID: 4426045
[No Abstract] [Full Text] [Related]
7. Pilot studies of various combinations of dibromodulcitol, VP-16, and AMSA.
Eagan RT
Oncology; 1982; 39(5):295-7. PubMed ID: 6896559
[TBL] [Abstract][Full Text] [Related]
8. Dibromodulcitol in the treatment of breast cancer.
Falkson G; Pretorius L; Falkson HC
Cancer Treat Rev; 1982 Dec; 9(4):261-6. PubMed ID: 6762921
[No Abstract] [Full Text] [Related]
9. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD.
Horváth IP; Csetényi J; Hindy I; Kerpel-Fronius S; Institoris I; Hegedüs I; Eckhardt S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1211-9. PubMed ID: 6891658
[TBL] [Abstract][Full Text] [Related]
10. [Dibromodulcitol in combination with actinotherapy of spinocellular carcinoma].
Petruzelka L; Konopásek B; Betka J; Klozar J; Kvapil F; Mazánek J; Růzicka V; Prokes K
Sb Lek; 1984 Sep; 86(8-9):259-64. PubMed ID: 6505608
[No Abstract] [Full Text] [Related]
11. Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone (CMFVP).
DiStefano A; Yap HY; Blumenschein GR
Cancer Treat Rep; 1981; 65(1-2):33-8. PubMed ID: 7013977
[TBL] [Abstract][Full Text] [Related]
12. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
Vitanovics D; Sipos L; Afra D
Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an intermittent schedule of dibromodulcitol in breast cancer.
Tormey DC; Falkson G; Perlin E; Bull J; Blom J; Lippman ME
Cancer Treat Rep; 1976 Nov; 60(11):1593-6. PubMed ID: 1035505
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced adenocarcinoma of the kidney with mitolactol: a Southeastern Cancer Study Group Trial.
Brubaker LH; Nelson MO; Birch R; Williams S
Cancer Treat Rep; 1986 Feb; 70(2):305-6. PubMed ID: 3948194
[No Abstract] [Full Text] [Related]
15. [The effectivity of carminomycin in combination with dibromodulcitol on human tumor cells in vitro (author's transl)].
Projan A; Nissen E; Tanneberger S
Arch Geschwulstforsch; 1981; 51(6):497-502. PubMed ID: 7332443
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
Hildebrand J; Gorlia T; Kros JM; Afra D; Frenay M; Omuro A; Stupp R; Lacombe D; Allgeier A; van den Bent MJ;
Eur J Cancer; 2008 Jun; 44(9):1210-6. PubMed ID: 18248979
[TBL] [Abstract][Full Text] [Related]
17. Dibromodulcitol.
Mischler NE; Earhart RH; Carr B; Tormey DC
Cancer Treat Rev; 1979 Sep; 6(3):191-204. PubMed ID: 394837
[No Abstract] [Full Text] [Related]
18. A phase II study of dibromodulcitol (DBD) in stage IV melanoma.
Hopkins J; Richards F; Case D; Pope E; Jackson DV; Stuart JJ; Muss HB; White DR; Cooper MR; Spurr CL
Am J Clin Oncol; 1984 Oct; 7(5):555-6. PubMed ID: 6507378
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
Nowak C; Arnold W; Henneberger G; Tanneberger S
Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of mitolactol in advanced malignant melanoma.
Murray N; Silver H; Shah A; Wilson K
Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
